Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Nab-paclitaxel vs Nab-paclitaxel in High-risk Elderly Advanced NSCLC
NCT02590003Phase 2Terminated
- Sponsor
- Yale University
- Start
- Nov 2015
- Primary completion
- Sep 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in non-small cell lung cancer (NSCLC), sponsored by Yale University. Started Nov 2015; status: terminated.
02
Drugs
carboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02590003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590003.